MYH1
Basic information
Region (hg38): 17:10492307-10518542
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MYH1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 114 | 116 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 116 | 5 | 1 |
Variants in MYH1
This is a list of pathogenic ClinVar variants found in the MYH1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-10492430-T-C | not specified | Uncertain significance (Dec 20, 2023) | ||
17-10492499-G-A | not specified | Uncertain significance (May 11, 2022) | ||
17-10492505-C-T | not specified | Uncertain significance (Apr 20, 2024) | ||
17-10492511-C-G | not specified | Uncertain significance (Nov 21, 2022) | ||
17-10492523-G-T | not specified | Uncertain significance (Nov 17, 2022) | ||
17-10492534-C-T | not specified | Uncertain significance (Nov 14, 2023) | ||
17-10492559-A-T | not specified | Uncertain significance (May 29, 2024) | ||
17-10494370-C-T | not specified | Uncertain significance (Apr 20, 2024) | ||
17-10494426-A-C | not specified | Uncertain significance (Jul 15, 2021) | ||
17-10494437-G-A | not specified | Uncertain significance (Dec 11, 2023) | ||
17-10494438-G-A | Likely benign (Jan 01, 2023) | |||
17-10494448-G-C | not specified | Uncertain significance (Jan 07, 2022) | ||
17-10494606-C-T | not specified | Uncertain significance (Apr 26, 2024) | ||
17-10494607-G-A | not specified | Uncertain significance (Aug 20, 2023) | ||
17-10494998-C-T | not specified | Uncertain significance (May 09, 2024) | ||
17-10494999-G-A | not specified | Uncertain significance (Mar 01, 2023) | ||
17-10495023-G-T | not specified | Uncertain significance (Nov 03, 2022) | ||
17-10495043-C-T | not specified | Uncertain significance (Mar 16, 2022) | ||
17-10495065-C-T | not specified | Uncertain significance (Jun 29, 2023) | ||
17-10495220-T-C | not specified | Uncertain significance (May 01, 2024) | ||
17-10495226-T-C | not specified | Uncertain significance (Jul 29, 2022) | ||
17-10495253-A-G | not specified | Uncertain significance (Dec 11, 2023) | ||
17-10495259-C-T | not specified | Uncertain significance (Dec 02, 2021) | ||
17-10495302-T-C | not specified | Uncertain significance (Feb 13, 2024) | ||
17-10495304-A-G | not specified | Uncertain significance (Nov 09, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MYH1 | protein_coding | protein_coding | ENST00000226207 | 38 | 26237 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.36e-56 | 1.94e-7 | 123638 | 15 | 2095 | 125748 | 0.00843 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0357 | 1027 | 1.03e+3 | 0.997 | 0.0000576 | 12939 |
Missense in Polyphen | 376 | 391.65 | 0.96003 | 5226 | ||
Synonymous | -1.73 | 424 | 381 | 1.11 | 0.0000208 | 3497 |
Loss of Function | 0.850 | 91 | 100 | 0.908 | 0.00000528 | 1234 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0367 | 0.0363 |
Ashkenazi Jewish | 0.00992 | 0.00997 |
East Asian | 0.0143 | 0.0141 |
Finnish | 0.00836 | 0.00835 |
European (Non-Finnish) | 0.00383 | 0.00382 |
Middle Eastern | 0.0143 | 0.0141 |
South Asian | 0.00517 | 0.00511 |
Other | 0.00703 | 0.00686 |
dbNSFP
Source:
- Function
- FUNCTION: Muscle contraction.;
- Pathway
- Tight junction - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.306
Intolerance Scores
- loftool
- 0.126
- rvis_EVS
- -1.08
- rvis_percentile_EVS
- 7.25
Haploinsufficiency Scores
- pHI
- 0.691
- hipred
- Y
- hipred_score
- 0.635
- ghis
- 0.491
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.765
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Myh1
- Phenotype
- skeleton phenotype; renal/urinary system phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype; muscle phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype;
Gene ontology
- Biological process
- muscle contraction
- Cellular component
- muscle myosin complex;intercalated disc;A band;myosin filament;cytoplasmic ribonucleoprotein granule
- Molecular function
- motor activity;protein binding;calmodulin binding;ATP binding;actin filament binding